Dr. Rebecca Brown and Dr. Elif Oral are already members of the AELIP expert committee.
Rebecca Brown graduated from Rice Mayo Medical School, where she completed her studies in pediatrics. Rebecca is a resident at Rainbow Babies and Children's Hospital.
In 2005, she began at the National Institutes of Health with a fellowship in pediatric endocrinology and has remained in the NIH intramural research program ever since.
In 2015, she became the first Lasker Research Fellow at NIDDK. Her research focuses on pathophysiology and clinical therapeutics for rare disorders of extreme insulin resistance, including lipodystrophy and insulin receptor dysfunction, as well as the mechanisms of action of leptin to improve metabolic disease.
Elif Oral is Professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan and a member of the American Society for Clinical Research (ASCI).
Professor Elif completed her medical education in her native Turkey and more specifically at Istanbul University.
In 1996, she completed her residency in Internal Medicine at Sinai Hospital in Detroit, Michigan. She then completed a Fellowship in Endocrinology, Metabolism and Diabetes at the National Institutes of Health, where she also chose to remain a Senior Fellow under the tutelage of Dr. Simeon Taylor and Dr. Phillip Gorden at the NIDDK Diabetes Branch.
Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, she combines her teaching responsibilities with the above.
Elif also completed a Masters of Clinical Science Research Design and Biostatistics at the School of Public Health. She obtained her position in Michigan in 2011.
Dr. Oral's research focuses on the importance of adipocytes in human metabolism and adipocytes hormones such as leptin.
This health professional is also known for her work demonstrating the efficacy of leptin in infrequent lipodystrophic syndromes.
They are currently working on the development of additional therapies and on improving the treatment algorithms for various lipodystrophies in an attempt to improve the accuracy of clinical results.
In addition to her role as a physician, educator, and researcher, she is also director of three unique clinical programs at Michigan Medicine:
Atypical Diabetes Program, Post Bariatric Surgery, Program and Obesity and Metabolic Disorders
With these great incorporations the committee of experts of AELIP counts for the first time with two professionals of the USA that work in the field of the Lipodystrophies endowing with more prestige this resource that AELIP implements to improve the quality of life of the people and families that coexist with a Lipodystrophy in the world.
AELIP reminds that in order to be part of this committee must meet the criteria and requirements that can be found at the following link: http://www.aelip.es/comite-expertosasesores-lipodistrofias.asp
